NM_002224.4:c.1148+39G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002224.4(ITPR3):c.1148+39G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 1,609,442 control chromosomes in the GnomAD database, including 69,860 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.24 ( 4866 hom., cov: 32)
Exomes 𝑓: 0.29 ( 64994 hom. )
Consequence
ITPR3
NM_002224.4 intron
NM_002224.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.61
Publications
11 publications found
Genes affected
ITPR3 (HGNC:6182): (inositol 1,4,5-trisphosphate receptor type 3) This gene encodes a receptor for inositol 1,4,5-trisphosphate, a second messenger that mediates the release of intracellular calcium. The receptor contains a calcium channel at the C-terminus and the ligand-binding site at the N-terminus. Knockout studies in mice suggest that type 2 and type 3 inositol 1,4,5-trisphosphate receptors play a key role in exocrine secretion underlying energy metabolism and growth. [provided by RefSeq, Aug 2010]
ITPR3 Gene-Disease associations (from GenCC):
- Charcot-Marie-Tooth disease, demyelinating, type 1JInheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 6-33663919-G-A is Benign according to our data. Variant chr6-33663919-G-A is described in ClinVar as Benign. ClinVar VariationId is 1269800.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.42 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.241 AC: 36574AN: 151944Hom.: 4863 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
36574
AN:
151944
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.286 AC: 70648AN: 247188 AF XY: 0.294 show subpopulations
GnomAD2 exomes
AF:
AC:
70648
AN:
247188
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.294 AC: 427826AN: 1457380Hom.: 64994 Cov.: 34 AF XY: 0.296 AC XY: 214483AN XY: 724776 show subpopulations
GnomAD4 exome
AF:
AC:
427826
AN:
1457380
Hom.:
Cov.:
34
AF XY:
AC XY:
214483
AN XY:
724776
show subpopulations
African (AFR)
AF:
AC:
4426
AN:
33446
American (AMR)
AF:
AC:
10737
AN:
44522
Ashkenazi Jewish (ASJ)
AF:
AC:
4474
AN:
25886
East Asian (EAS)
AF:
AC:
17327
AN:
39656
South Asian (SAS)
AF:
AC:
32506
AN:
85954
European-Finnish (FIN)
AF:
AC:
15895
AN:
52578
Middle Eastern (MID)
AF:
AC:
1167
AN:
5630
European-Non Finnish (NFE)
AF:
AC:
324303
AN:
1109496
Other (OTH)
AF:
AC:
16991
AN:
60212
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
14711
29423
44134
58846
73557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11000
22000
33000
44000
55000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.241 AC: 36598AN: 152062Hom.: 4866 Cov.: 32 AF XY: 0.245 AC XY: 18186AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
36598
AN:
152062
Hom.:
Cov.:
32
AF XY:
AC XY:
18186
AN XY:
74310
show subpopulations
African (AFR)
AF:
AC:
5649
AN:
41516
American (AMR)
AF:
AC:
3573
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
594
AN:
3472
East Asian (EAS)
AF:
AC:
2244
AN:
5160
South Asian (SAS)
AF:
AC:
1827
AN:
4806
European-Finnish (FIN)
AF:
AC:
3084
AN:
10572
Middle Eastern (MID)
AF:
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18785
AN:
67932
Other (OTH)
AF:
AC:
476
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1389
2778
4168
5557
6946
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
396
792
1188
1584
1980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1376
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.